Old Web
English
Sign In
Acemap
>
authorDetail
>
Eberhard Roeseler
Eberhard Roeseler
Internal medicine
Medicine
Cardiology
Diabetes mellitus
Coronary artery disease
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis
2019
Atherosclerosis Supplements
Reinhard Klingel
Franz Heigl
Volker Schettler
Eberhard Roeseler
P. Grützmacher
Bernd Hohenstein
Anja Vogt
Cordula Fassbender
Andreas Heibges
Ulrich Julius
Show All
Source
Cite
Save
Citations (3)
Stellenwert von Lipoproteinapherese und PCSK9-Antikörpern bei der Maximaltherapie schwerer Hyperlipoproteinämien
2019
Nieren-und Hochdruckkrankheiten
Franz Heigl
P. Grützmacher
Bernd Hohenstein
Ulrich Julius
Eberhard Roeseler
Volker Schettler
Anja Vogt
Andreas Heibges
Reinhard Klingel
Show All
Source
Cite
Save
Citations (0)
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
2019
Clinical Research in Cardiology Supplements
Volker Schettler
C. L. Neumann
C Peter
T. Zimmermann
Ulrich Julius
Bernd Hohenstein
Eberhard Roeseler
Franz Heigl
P. Grützmacher
H. Blume
Reinhard Klingel
Anja Vogt
Show All
Source
Cite
Save
Citations (7)
Lipoprotein apheresis in Germany – Still more commonly indicated than implemented. How can patients in need access therapy?
2019
Atherosclerosis Supplements
Franz Heigl
Tobias Pflederer
Reinhard Klingel
Reinhard Hettich
Norbert Lotz
Harduin Reeg
Volker Schettler
Eberhard Roeseler
P. Grützmacher
Bernd Hohenstein
Ulrich Julius
Show All
Source
Cite
Save
Citations (1)
1